#HPV #vaccine #prevention #endcancer World Health Organization (WHO) ESGO IGCS FIGO HQ GYN Cancer | #GYNCSM SoMe4GynOnc Humanitas Milano Humanitas University OncoAlert

The OncoAlert Network along with our partners at European Society of Surgical Oncology (ESSO) ESGO MASCC & SIOG Proudly Announce the first 1/3 of our faculty, more to come very soon. Register for FREE HERE: buff.ly/3CChgre Hope Rugo 🇺🇸 Erika Hamilton, MD, FASCO 🇺🇸 silke gillessen 🇨🇭

A systematic review and meta-analysis of patient-relevant outcomes in comprehensive cancer centers versus noncomprehensive cancer centers Out in Cancer by ACS This systematic review compares patient-relevant outcomes between comprehensive cancer centers (CCCs) and non-CCCs.

#cervicalcancer treatment #endcancer pembrolizumab and CHT-RT as a new standard Humanitas Milano Humanitas University OncoAlert Gil Morgan, MD GYN Cancer | #GYNCSM SoMe4GynOnc FIGO HQ World Health Organization (WHO)

HIPEC in Platinum-Sensitive Recurrent #ovariancancer: RCT (HORSE; MITO-18) | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… 167 pts No NACT before SCS mPFS: - 23mo surgery alone - 25mo surgery + HIPEC No PFS benefit of adding HIPEC ESGO IGCS OncoAlert Gil Morgan, MD SoMe4GynOnc

Vaginal Estrogen Use in #breastcancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks AJOG ajog.org/article/S0002-… No ⬆️ recurrences No ⬆️ mortality ‼️Better #QoL‼️ OncoAlert Gil Morgan, MD SoMe4GynOnc GYN Cancer | #GYNCSM ESGO IGCS

Artificial intelligence-aided data mining of medical records for cancer detection and screening out on The Lancet Oncology This review explores the use of artificial intelligence ( #AI ) in analyzing electronic patient records to enhance early #cancer detection and screening. By

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020 Out on JAMA Oncology This model-based study assessed the impact of prevention, screening, and treatment on reducing cancer mortality in the U.S. from 1975 to 2020, focusing on

#HPV reccomendations H2020 RISCC project European Commission Cancer Core Europe European Network of Young Gynae Oncologists European Cancer Organisation OncoAlert #endcancer #cervicalcancer HPVWorld ENGAGe.ESGO ESGO IGCS Humanitas Milano Humanitas University

At #SABCS24 session chaired by Matteo Lambertini, MD PhD on breast cancer in young women Prudence Francis talks about ovarian suppression - very young women should be considered for OFS, and absolute benefit is correlated to baseline recurrence risk OncoAlert

#uterine pathology #sarcoma #diagnostic tools OncoAlert GYN Cancer | #GYNCSM SoMe4GynOnc ESGO IGCS European Network of Young Gynae Oncologists Sarcoma Foundation of America

⁦IARC⁩ marks #CervicalCancer #Awareness Month 2025 January #endcervicalcancer 90-70-90 World Health Organization (WHO)⁩ ⁦ESGO⁩ ⁦ENGAGe.ESGO⁩ ⁦IGCS⁩ ⁦GYN Cancer | #GYNCSM⁩ ⁦OncoAlert⁩ ⁦SoMe4GynOnc⁩ ⁦Humanitas Milano⁩ iarc.who.int/featured-news/…

#CervicalCancerAwarenessMonth #HPV #screening #endcancer World Health Organization (WHO) FIGO HQ ESGO ENGAGe.ESGO IGCS IJGC European Network of Young Gynae Oncologists OncoAlert Gil Morgan, MD GYN Cancer | #GYNCSM SoMe4GynOnc Humanitas Milano

International multicenter validation of AI-driven ultrasound detection of ovarian cancer | ⁦Nature Medicine⁩ ⁦OncoAlert⁩ ⁦Gil Morgan, MD⁩ ⁦ESGO⁩ ⁦IGCS⁩ ⁦Humanitas Milano⁩ ⁦SoMe4GynOnc⁩ nature.com/articles/s4159…

Debate! #MIS in #cervicalcancer #ESGO2025 ESGO

‼️must read‼️ #Fertility Preservation in People With #Cancer: ASCO Guideline Update | @JCO. ascopubs.org/doi/10.1200/JC… ESGO OncoAlert Gil Morgan, MD IGCS ENGAGe.ESGO Humanitas University Humanitas Milano SoMe4GynOnc

TRUST: Trial of radical upfront surgical therapy in advanced #ovarian cancer (ENGOT ov33/AGO‐OVAR OP7). - #ASCO25 ⁦ESGO⁩ ⁦IGCS⁩ ⁦SGO⁩ ⁦IJGC⁩ asco.org/abstracts-pres…